Cargando…
Anti-PRL-3 Monoclonal Antibody inhibits the Growth and Metastasis of colorectal adenocarcinoma
Background: Colon cancer is the one of leading causes of cancer-related death. Chemotherapy, radiotherapy and immunotherapy will be the mainstream in inoperable advanced cancer in clinics. Precision treatment is still lack in colon cancer. Materials and Methods: We developed a series of mAbs targeti...
Autores principales: | Sun, Shuning, Meng, Lin, Xing, Xiaofang, Li, Ningning, Song, Qian, Qiao, Dongbo, Qu, Like, Liu, Caiyun, An, Guo, Li, Zhongwu, Shou, Chenchao, Lian, Shenyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475362/ https://www.ncbi.nlm.nih.gov/pubmed/37670977 http://dx.doi.org/10.7150/jca.81702 |
Ejemplares similares
-
PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin β1-ERK1/2 and-MMP2 signaling
por: Peng, Lirong, et al.
Publicado: (2009) -
PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer
por: Lian, Shenyi, et al.
Publicado: (2016) -
PRL-3 promotes telomere deprotection and chromosomal instability
por: Lian, Shenyi, et al.
Publicado: (2017) -
Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion
por: Yang, Yongyong, et al.
Publicado: (2017) -
Phosphatase of regenerating liver-3 (PRL-3) is associated with metastasis and poor prognosis in gastric carcinoma
por: Xing, Xiaofang, et al.
Publicado: (2013)